EFFECT OF ADALIMUMAB ON CLINICAL AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES BY DISEASE SEVERITY AND PRIOR TUMOUR NECROSIS FACTOR INHIBITOR USE IN PATIENTS WITH ULCERATIVE COLITIS IN A CLINICAL PRACTICE SETTING: SUBGROUP ANALYSES FROM INSPIRADA

Simon Travis  1     Brian G. Feagan  2     Laurent Peyrin-Biroulet  3     Remo Panaccione  4     Silvio Danese  5     Joel Petersson  6     Andreas Lazar  7     Anne M. Robinson  8     Naijun Chen     Martha Skup     Wan-Ju Lee    
1 Oxford University Hospitals,Oxford,United Kingdom
2 Robarts Research Institute,London,Canada
3 University Hospital of Nancy,Les Nancy,France
4 University of Calgary,Calgary,Canada
5 Istituto Clinico Humanitas,Milan,Italy
6 AbbVie Inc.,North Chicago,United States of America
7 AbbVie Deutschland GmbH & Co. KG,Ludwigshafen,Germany
8 AbbVi

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing